Late results of percutaneous mitral commissurotomy up to 20 years: Development and validation of a risk score predicting late functional results from a series of 912 patients

Circulation

Volumn 125, Issue 17, 2012, Pages 2119-2127

  Bouleti, Claire ^a   Iung, Bernard ^a   Laouénan, Cédric ^b   Himbert, Dominique ^a   Brochet, Eric ^a   Messika Zeitoun, David ^a   Détaint, Delphine ^a   Garbarz, Eric ^a   Cormier, Bertrand ^a   Michel, Pierre Louis ^c   Mentré, France ^b   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Balloon dilation; Follow up studies; Mitral valve stenosis; Statistics

Indexed keywords

ADULT; AGE; ANATOMY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; MALE; MITRAL VALVE; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE REGURGITATION; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SCORING SYSTEM; SEX; STROKE; SURVIVAL; UNITED STATES; VALIDATION STUDY;

ADULT; AGED; BALLOON DILATION; CALCINOSIS; CALIBRATION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84860330305     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.055905     Document Type: Article

References (38)

1. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87:394-402.
2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118: e523-e661.
3. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.
4. Iung B, Nicoud-Houel A, Fondard O, Hafid A, Haghighat T, Brochet E, Garbarz E, Cormier B, Baron G, Luxereau P, Vahanian A. Temporal trends in percutaneous mitral commissurotomy over a 15-year period. Eur Heart J. 2004;25:701-707.
5. Cohen DJ, Kuntz RE, Gordon SP, Piana RN, Safian RD, McKay RG, Baim DS, Grossman W, Diver DJ. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med. 1992;327: 1329-1335.
6. Dean LS, Mickel M, Bonan R, Holmes DR Jr, O'Neill WW, Palacios IF, Rahimtoola S, Slater JN, Davis K, Kennedy JW. Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. J Am Coll Cardiol. 1996;28:1452-1457.
7. Orrange SE, Kawanishi DT, Lopez BM, Curry SM, Rahimtoola SH. Actuarial outcome after catheter balloon commissurotomy in patients with mitral stenosis. Circulation. 1997;95:382-389.
8. Meneveau N, Schiele F, Seronde MF, Breton V, Gupta S, Bernard Y, Bassand JP. Predictors of event-free survival after percutaneous mitral commissurotomy. Heart. 1998;80:359-364.
9. Stefanadis CI, Stratos CG, Lambrou SG, Bahl VK, Cokkinos DV, Voudris VA, Foussas SG, Tsioufis CP, Toutouzas PK. Retrograde nontransseptal balloon mitral valvuloplasty: immediate results and intermediate long-term outcome in 441 cases: a multicenter experience. J Am Coll Cardiol. 1998;32:1009-1016.
10. Hernandez R, Banuelos C, Alfonso F, Goicolea J, Fernandez-Ortiz A, Escaned J, Azcona L, Almeria C, Macaya C. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation. 1999;99:1580-1586.
11. Iung B, Garbarz E, Michaud P, Helou S, Farah B, Berdah P, Michel PL, Cormier B, Vahanian A. Late results of percutaneous mitral commissurotomy in a series of 1024 patients. Analysis of late clinical deterioration: frequency, anatomic findings, and predictive factors. Circulation. 1999;99:3272-3278.
12. Ben-Farhat M, Betbout F, Gamra H, Maatouk F, Ben-Hamda K, Abdellaoui M, Hammami S, Jarrar M, Addad F, Dridi Z. Predictors of long-term event-free survival and of freedom from restenosis after per-cutaneous balloon mitral commissurotomy. Am Heart J. 2001;142: 1072-1079.
13. Wang A, Krasuski RA, Warner JJ, Pieper K, Kisslo KB, Bashore TM, Harrison JK. Serial echocardiographic evaluation of restenosis after successful percutaneous mitral commissurotomy. J Am Coll Cardiol. 2002; 39:328-334.
14. Song JK, Song JM, Kang DH, Yun SC, Park DW, Lee SW, Kim YH, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate post-procedural mitral valve area as an important prognosticator. Eur Heart J. 2009;30:1254-1262.
15. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105:1465-1471.
16. Fawzy ME. Long-term results up to 19 years of mitral balloon valvuloplasty. Asian Cardiovasc Thorac Ann. 2009;17:627-633.
17. Ellis LB, Singh JB, Morales DD, Harken DE. Fifteen-to twenty-year study of one thousand patients undergoing closed mitral valvuloplasty. Circulation. 1973;48:357-364.
18. John S, Bashi VV, Jairaj PS, Muralidharan S, Ravikumar E, Rajarajeswari T, Krishnaswami S, Sukumar IP, Rao PS. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients. Circulation. 1983;68:891-896.
19. Rihal CS, Schaff HV, Frye RL, Bailey KR, Hammes LN, Holmes DR Jr. Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? J Am Coll Cardiol. 1992;20:781-786.
20. Detter C, Fischlein T, Feldmeier C, Nollert G, Reichenspurner H, Reichart B. Mitral commissurotomy, a technique outdated? Long-term follow-up over a period of 35 years. Ann Thorac Surg. 1999;68: 2112-2118.
21. Iung B, Cormier B, Ducimetiere P, Porte JM, Nallet O, Michel PL, Acar J, Vahanian A. Immediate results of percutaneous mitral commissurotomy: a predictive model on a series of 1514 patients. Circulation. 1996;94:2124-2130.
22. Cruz-Gonzalez I, Sanchez-Ledesma M, Sanchez PL, Martin-Moreiras J, Jneid H, Rengifo-Moreno P, Inglessis-Azuaje I, Maree AO, Palacios IF. Predicting success and long-term outcomes of percutaneous mitral valvuloplasty: a multifactorial score. Am J Med. 2009;122:581.e11-581.e19.
23. Cormier B, Vahanian A, Michel PL, Starkman C, Enriquez L, Kulas A, Vitoux B, Acar J. Evaluation by two-dimensional and Doppler echocardiography of the results of percutaneous mitral valvuloplasty. Arch Mal Coeur. 1989;82:185-191.
24. Vahanian A, Michel PL, Cormier B, Vitoux B, Michel X, Slama M, Sarano LE, Trabelsi S, Ben Ismail M, Acar J. Results of percutaneous mitral commissurotomy in 200 patients. Am J Cardiol. 1989;63:847-852.
25. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, Gatewood RP Jr. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 1987;75:175-183.
26. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109-2123.
27. Haibe-Kains B, Desmedt C, Sotiriou C, Bontempi G. A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? Bioinformatics. 2008; 24:2200-2208.
28. Iung B, Cormier B, Ducimetiere P, Porte JM, Nallet O, Michel PL, Acar J, Vahanian A. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol. 1996;27:407-414.
29. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1-23.
30. Okay T, Deligonul U, Sancaktar O, Kozan O. Contribution of mitral valve reserve capacity to sustained symptomatic improvement after balloon valvulotomy in mitral stenosis: implications for restenosis. J Am Coll Cardiol. 1993;22:1691-1696.
31. Fatkin D, Roy P, Morgan JJ, Feneley MP. Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol. 1993;21: 390-397.
32. Cannan CR, Nishimura RA, Reeder GS, Ilstrup DR, Larson DR, Holmes DR, Tajik AJ. Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy. J Am Coll Cardiol. 1997;29:175-180.
33. Sutaria N, Shaw TR, Prendergast B, Northridge D. Transoesophageal echocardiographic assessment of mitral valve commissural morphology predicts outcome after balloon mitral valvotomy. Heart. 2006;92:52-57.
34. Herrmann HC, Ramaswamy K, Isner JM, Feldman TE, Carroll JD, Pichard AD, Bashore TM, Dorros G, Massumi GA, Sundram P, et al. Factors influencing immediate results, complications, and short-term follow-up status after Inoue balloon mitral valvotomy: a North American multicenter study. Am Heart J. 1992;124:160-166.
35. Song JK, Kim MJ, Yun SC, Choo SJ, Song JM, Song H, Kang DH, Chung CH, Park DW, Lee SW, Kim YH, Lee CW, Hong MK, Kim JJ, Lee JW, Park SW, Park SJ. Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery. J Thorac Cardiovasc Surg. 2010;139:103-110.
36. Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol. 2007;32:609-661.
37. Kang DH, Park SW, Song JK, Kim HS, Hong MK, Kim JJ, Park SJ. Long-term clinical and echocardiographic outcome of percutaneous mitral valvuloplasty: randomized comparison of Inoue and doubleballoon techniques. J Am Coll Cardiol. 2000;35:169-175.
38. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:1317-1320.